04:17

Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell...

10:55

Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stag...

05:31

Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple nega...

05:41

A combined PET-MRI scan could improve treatment for patients with early breast cancer

07:32

Linvoseltamab induces deep and durable responses in patients with relapsed or refractory multipl...

03:07

Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours

04:30

Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate ...

08:50

Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in ...

05:04

Blood test may identify patients with non-small cell lung cancer subtype who can benefit from co...

03:39

Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype

04:31

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoi...

08:12

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

05:19

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients

06:20

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer

11:38

Treatment of multiple myeloma in Singapore and across Asia

06:33

Using AI to identify patients at increased risk of side effects from radiation treatment for bre...

06:34

Optimising multiple myeloma care in Latin America

08:48

Special Issue on paediatric oncology

03:48

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows effic...

11:10

Remote genetic testing has the potential to increase the uptake of testing in large integrated h...

04:29

Trifluridine/tipiracil and bevacizumab combination shows prolonged PFS compared to trifluridine/...

05:13

Pembrolizumab can be a promising option for MIUC patients after radical surgery

07:23

Durvalumab plus bevacizumab, added to TACE, shows benefit for unresectable hepatocellular carcinoma

04:07

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

04:46

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

05:37

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

30:20

What's new on ADCs in management of advanced NSCLC

23:05

Personalised systemic treatment in advanced prostate cancer

21:12

What is new for treatment of soft tissue and bone sarcomas?

14:36

Cancer personomics: Launching the missile - Localised endometrial carcinoma.

13:58

Novel therapies and combinations in ovarian cancer

10:22

Treatment of metastatic NSCLC without PD-L1 expression and without oncogene addiction

05:47

Clinical Research Mentorship Program for LMICs

04:03

Genetic testing and targeted therapy in Ivory Coast

01:20

Growing research capacity through distant learning, mentorship and international partnership

08:12

Development of AORTIC oncology nursing competencies in sub-Sahran Africa

04:46

Colorectal cancer risk factors in Nigeria

02:58

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

05:24

The role of nurses in the fight against cervical cancer in Cameroon

14:51

Choosing Wisely Africa conferences

09:49

The human inside oncology

08:54

Implementation of the Choosing Wisely Africa List in 3 Countries

08:58

Conflicts of interest in oncology

04:42

T-DM1 may extend PFS among patients with unresectable locally advanced or metastatic HER2-positi...

05:38

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituxima...

05:15

Impact of age and ovarian function suppression on endocrine response to short preoperative endoc...

03:54

Enhanced health-related quality of life (HRQoL) with ide-cel treatment in patients with refracto...

05:01

Significant clinical benefits observed with revumenib monotherapy in relapsed/refractory KMT2Ar ...

14:51

Applying Choosing Wisely in radiation oncology in Africa

03:04

Ponatinib is superior to imatinib in combination with chemotherapy for patients with newly diagn...

04:49

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer ...

07:43

Beat AML master trial: A clinical trial for acute myeloid leukaemia

03:54

BrECADD regimen combined with PET2-guided treatment sets a new benchmark for the treatment of ne...

06:41

The addition of nivolumab to R-GemOx followed by nivolumab maintenance shows a trend towards bet...

15:05

Choosing Wisely Africa

03:19

Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC

06:13

Toripalimab plus metronomic chemotherapy show efficacy in treating in HER2-negative metastatic b...

06:10

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for sol...

07:29

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/...

04:09

Cancer care in Needle Hospital, Hargeisa, Somaliland